SEC Form 4 · accession 0001645627-17-000010
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 19, 2017
Accepted (ET)
Feb 28, 2017 · 8:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 19, 2017 | P | 200 | $0.0329 | A | 19,646,849 | D | |
| Common Stock | Jan 19, 2017 | P | 1,000 | $0.03 | A | 19,647,849 | D | |
| Common Stock | Jan 19, 2017 | P | 1,000 | $0.0314 | A | 19,648,849 | D | |
| Common Stock | Jan 19, 2017 | P | 500 | $0.032 | A | 19,649,349 | D | |
| Common Stock | Jan 19, 2017 | P | 1,000 | $0.32 | A | 19,650,349 | D | |
| Common Stock | Jan 19, 2017 | P | 1,000 | $0.032 | A | 19,651,349 | D | |
| Common Stock | Jan 19, 2017 | P | 1,000 | $0.0359 | A | 19,652,349 | D | |
| Common Stock | Jan 19, 2017 | P | 200 | $0.038 | A | 19,652,549 | D | |
| Common Stock | Jan 19, 2017 | P | 500 | $0.0377 | A | 19,653,049 | D | |
| Common Stock | Jan 19, 2017 | P | 200 | $0.038 | A | 19,653,249 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0345 | A | 19,654,249 | D | |
| Common Stock | Jan 20, 2017 | P | 500 | $0.0345 | A | 19,654,949 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0344 | A | 19,655,749 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0344 | A | 19,656,749 | D | |
| Common Stock | Jan 20, 2017 | P | 500 | $0.0307 | A | 19,657,249 | D | |
| Common Stock | Jan 20, 2017 | P | 500 | $0.0344 | A | 19,657,749 | D | |
| Common Stock | Jan 20, 2017 | P | 500 | $0.0333 | A | 19,658,249 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0366 | A | 19,659,249 | D | |
| Common Stock | Jan 20, 2017 | P | 500 | $0.0366 | A | 19,659,749 | D | |
| Common Stock | Jan 20, 2017 | P | 200 | $0.0361 | A | 19,659,949 | D | |
| Common Stock | Jan 20, 2017 | P | 200 | $0.0363 | A | 19,660,149 | D | |
| Common Stock | Jan 20, 2017 | P | 200 | $0.0359 | A | 19,660,349 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0339 | A | 19,661,349 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0323 | A | 19,662,349 | D | |
| Common Stock | Jan 20, 2017 | P | 1,000 | $0.0315 | A | 19,663,349 | D | |
| Common Stock | Jan 23, 2017 | P | 50 | $0.0327 | A | 19,663,399 | D | |
| Common Stock | Jan 23, 2017 | P | 950 | $0.0332 | A | 19,664,349 | D | |
| Common Stock | Jan 23, 2017 | P | 500 | $0.0329 | A | 19,664,849 | D | |
| Common Stock | Jan 23, 2017 | P | 500 | $0.0326 | A | 19,665,349 | D | |
| Common Stock | Jan 23, 2017 | P | 500 | $0.0326 | A | 19,665,849 | D |
Table II — derivative securities
No Table II lines on this filing.